| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/26/2026 | ±2.3% | +0.3% | over-priced |
| 05/27/2026 | ±3.6% | -1.6% | over-priced |
| 02/25/2026 | ±4.5% | +1.9% | over-priced |
| 09/09/2025 | ±2.8% | -0.8% | over-priced |
| 05/28/2025 | ±2.3% | -9.6% | under-priced |
| 02/26/2025 | ±4.4% | +2.7% | over-priced |
| 08/23/2024 | ±3.2% | -1.6% | over-priced |
| 05/24/2024 | ±2.5% | +0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.84 | $2.5B | $546M |
| Q2 FY2026 | $0.09 | $2.3B | $17M |
| Q1 FY2026 | $0.34 | $2.4B | $65M |
| Q4 FY2025 | $2.45 | $2.3B | $448M |
Synopsys Inc (SNPS) reports in 101 days, with the next report estimated for 12/17/2026. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 2.3% on average — the market has systematically over-priced SNPS's earnings risk. Fundamentals into the print: EPS up 89.3% year-over-year, revenue up 42.4%. QuantLogix's live 5-factor engine currently reads SNPS as a neutral at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →